Global Oligonucleotide API Market Research Report 2021

1 Oligonucleotide API Market Overview

• 1.1 Product Overview and Scope of Oligonucleotide API
• 1.2 Oligonucleotide API Segment by Type
  • 1.2.1 Global Oligonucleotide API Market Size Growth Rate Analysis by Type 2021 VS 2027
  • 1.2.2 Antisense Oligonucleotides API
  • 1.2.3 Small Interfering RNA (siRNA) API
  • 1.2.4 MiRNA API
  • 1.2.5 CpG Oligonucleotides API
  • 1.2.6 Others
• 1.3 Oligonucleotide API Segment by Application
  • 1.3.1 Global Oligonucleotide API Consumption Comparison by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Contract Manufacturing Organizations (CMOs)
  • 1.3.3 Pharmaceutical Companies
• 1.4 Global Market Growth Prospects
  • 1.4.1 Global Oligonucleotide API Revenue Estimates and Forecasts (2016-2027)
  • 1.4.2 Global Oligonucleotide API Production Capacity Estimates and Forecasts (2016-2027)
  • 1.4.3 Global Oligonucleotide API Production Estimates and Forecasts (2016-2027)
• 1.5 Global Oligonucleotide API Market by Region
  • 1.5.1 Global Oligonucleotide API Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027
  • 1.5.2 North America Oligonucleotide API Estimates and Forecasts (2016-2027)
  • 1.5.3 Europe Oligonucleotide API Estimates and Forecasts (2016-2027)
  • 1.5.5 China Oligonucleotide API Estimates and Forecasts (2016-2027)
  • 1.5.5 Japan Oligonucleotide API Estimates and Forecasts (2016-2027)

2 Market Competition by Manufacturers

• 2.1 Global Oligonucleotide API Production Capacity Market Share by Manufacturers (2016-2021)
• 2.2 Global Oligonucleotide API Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Oligonucleotide API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.4 Global Oligonucleotide API Average Price by Manufacturers (2016-2021)
• 2.5 Manufacturers Oligonucleotide API Production Sites, Area Served, Product Types
• 2.6 Oligonucleotide API Market Competitive Situation and Trends
  • 2.6.1 Oligonucleotide API Market Concentration Rate
  • 2.6.2 Global 5 and 10 Largest Oligonucleotide API Players Market Share by Revenue
  • 2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region

• 3.1 Global Production Capacity of Oligonucleotide API Market Share by Region (2016-2021)
• 3.2 Global Oligonucleotide API Revenue Market Share by Region (2016-2021)
• 3.3 Global Oligonucleotide API Production, Revenue, Price and Gross Margin (2016-2021)
• 3.4 North America Oligonucleotide API Production
  • 3.4.1 North America Oligonucleotide API Production Growth Rate (2016-2021)
  • 3.4.2 North America Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.5 Europe Oligonucleotide API Production
  • 3.5.1 Europe Oligonucleotide API Production Growth Rate (2016-2021)
  • 3.5.2 Europe Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.6 China Oligonucleotide API Production
  • 3.6.1 China Oligonucleotide API Production Growth Rate (2016-2021)
  • 3.6.2 China Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.7 Japan Oligonucleotide API Production
  • 3.7.1 Japan Oligonucleotide API Production Growth Rate (2016-2021)
  • 3.7.2 Japan Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Oligonucleotide API Consumption by Region

• 4.1 Global Oligonucleotide API Consumption by Region
  • 4.1.1 Global Oligonucleotide API Consumption by Region
  • 4.1.2 Global Oligonucleotide API Consumption Market Share by Region
• 4.2 North America
  • 4.2.1 North America Oligonucleotide API Consumption by Country
  • 4.2.2 U.S.
  • 4.2.3 Canada
• 4.3 Europe
  • 4.3.1 Europe Oligonucleotide API Consumption by Country
  • 4.3.2 Germany
  • 4.3.3 France
  • 4.3.4 U.K.
  • 4.3.5 Italy
  • 4.3.6 Russia
• 4.4 Asia Pacific
  • 4.4.1 Asia Pacific Oligonucleotide API Consumption by Region
  • 4.4.2 China
  • 4.4.3 Japan
  • 4.4.4 South Korea
  • 4.4.5 Taiwan
  • 4.4.6 Southeast Asia
  • 4.4.7 India
  • 4.4.8 Australia
• 4.5 Latin America
  • 4.5.1 Latin America Oligonucleotide API Consumption by Country
  • 4.5.2 Mexico
  • 4.5.3 Brazil

5 Production, Revenue, Price Trend by Type

• 5.1 Global Oligonucleotide API Production Market Share by Type (2016-2021)
• 5.2 Global Oligonucleotide API Revenue Market Share by Type (2016-2021)
• 5.3 Global Oligonucleotide API Price by Type (2016-2021)

6 Consumption Analysis by Application

• 6.1 Global Oligonucleotide API Consumption Market Share by Application (2016-2021)
• 6.2 Global Oligonucleotide API Consumption Growth Rate by Application (2016-2021)

7 Key Companies Profiled

• 7.1 Jazz Pharmaceuticals
  • 7.1.1 Jazz Pharmaceuticals Oligonucleotide API Corporation Information
  • 7.1.2 Jazz Pharmaceuticals Oligonucleotide API Product Portfolio
  • 7.1.3 Jazz Pharmaceuticals Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.1.4 Jazz Pharmaceuticals Main Business and Markets Served
  • 7.1.5 Jazz Pharmaceuticals Recent Developments/Updates
• 7.2 Sarepta Therapeutics
  • 7.2.1 Sarepta Therapeutics Oligonucleotide API Corporation Information
  • 7.2.2 Sarepta Therapeutics Oligonucleotide API Product Portfolio
  • 7.2.3 Sarepta Therapeutics Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.2.4 Sarepta Therapeutics Main Business and Markets Served
  • 7.2.5 Sarepta Therapeutics Recent Developments/Updates
• 7.3 Biogen
  • 7.3.1 Biogen Oligonucleotide API Corporation Information
  • 7.3.2 Biogen Oligonucleotide API Product Portfolio
  • 7.3.3 Biogen Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.3.4 Biogen Main Business and Markets Served
  • 7.3.5 Biogen Recent Developments/Updates
• 7.4 Dynavax Technologies
  • 7.4.1 Dynavax Technologies Oligonucleotide API Corporation Information
  • 7.4.2 Dynavax Technologies Oligonucleotide API Product Portfolio
  • 7.4.3 Dynavax Technologies Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.4.4 Dynavax Technologies Main Business and Markets Served
  • 7.4.5 Dynavax Technologies Recent Developments/Updates
• 7.5 Akcea Therapeutics
  • 7.5.1 Akcea Therapeutics Oligonucleotide API Corporation Information
  • 7.5.2 Akcea Therapeutics Oligonucleotide API Product Portfolio
  • 7.5.3 Akcea Therapeutics Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.5.4 Akcea Therapeutics Main Business and Markets Served
  • 7.5.5 Akcea Therapeutics Recent Developments/Updates
• 7.6 Alnylam Pharmaceuticals
  • 7.6.1 Alnylam Pharmaceuticals Oligonucleotide API Corporation Information
  • 7.6.2 Alnylam Pharmaceuticals Oligonucleotide API Product Portfolio
  • 7.6.3 Alnylam Pharmaceuticals Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.6.4 Alnylam Pharmaceuticals Main Business and Markets Served
  • 7.6.5 Alnylam Pharmaceuticals Recent Developments/Updates
• 7.7 Nitto Denko (Avecia)
  • 7.7.1 Nitto Denko (Avecia) Oligonucleotide API Corporation Information
  • 7.7.2 Nitto Denko (Avecia) Oligonucleotide API Product Portfolio
  • 7.7.3 Nitto Denko (Avecia) Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.7.4 Nitto Denko (Avecia) Main Business and Markets Served
  • 7.7.5 Nitto Denko (Avecia) Recent Developments/Updates
• 7.8 Ajinomoto (GeneDesign)
  • 7.8.1 Ajinomoto (GeneDesign) Oligonucleotide API Corporation Information
  • 7.8.2 Ajinomoto (GeneDesign) Oligonucleotide API Product Portfolio
  • 7.8.3 Ajinomoto (GeneDesign) Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.8.4 Ajinomoto (GeneDesign) Main Business and Markets Served
  • 7.7.5 Ajinomoto (GeneDesign) Recent Developments/Updates
• 7.9 RiboBio
  • 7.9.1 RiboBio Oligonucleotide API Corporation Information
  • 7.9.2 RiboBio Oligonucleotide API Product Portfolio
  • 7.9.3 RiboBio Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.9.4 RiboBio Main Business and Markets Served
  • 7.9.5 RiboBio Recent Developments/Updates

8 Oligonucleotide API Manufacturing Cost Analysis

• 8.1 Oligonucleotide API Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Key Raw Materials Price Trend
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Oligonucleotide API
• 8.4 Oligonucleotide API Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
• 9.2 Oligonucleotide API Distributors List
• 9.3 Oligonucleotide API Customers

10 Market Dynamics

• 10.1 Oligonucleotide API Industry Trends
• 10.2 Oligonucleotide API Growth Drivers
• 10.3 Oligonucleotide API Market Challenges
• 10.4 Oligonucleotide API Market Restraints

11 Production and Supply Forecast

• 11.1 Global Forecasted Production of Oligonucleotide API by Region (2022-2027)
• 11.2 North America Oligonucleotide API Production, Revenue Forecast (2022-2027)
• 11.3 Europe Oligonucleotide API Production, Revenue Forecast (2022-2027)
• 11.4 China Oligonucleotide API Production, Revenue Forecast (2022-2027)
• 11.5 Japan Oligonucleotide API Production, Revenue Forecast (2022-2027)

12 Consumption and Demand Forecast

• 12.1 Global Forecasted Demand Analysis of Oligonucleotide API
• 12.2 North America Forecasted Consumption of Oligonucleotide API by Country
• 12.3 Europe Market Forecasted Consumption of Oligonucleotide API by Country
• 12.4 Asia Pacific Market Forecasted Consumption of Oligonucleotide API by Region
• 12.5 Latin America Forecasted Consumption of Oligonucleotide API by Country

13 Forecast by Type and by Application (2022-2027)

• 13.1 Global Production, Revenue and Price Forecast by Type (2022-2027)
  • 13.1.1 Global Forecasted Production of Oligonucleotide API by Type (2022-2027)
  • 13.1.2 Global Forecasted Revenue of Oligonucleotide API by Type (2022-2027)
  • 13.1.3 Global Forecasted Price of Oligonucleotide API by Type (2022-2027)
• 13.2 Global Forecasted Consumption of Oligonucleotide API by Application (2022-2027)

14 Research Finding and Conclusion

15 Methodology and Data Source

• 15.1 Methodology/Research Approach
  • 15.1.1 Research Programs/Design
  • 15.1.2 Market Size Estimation
  • 15.1.3 Market Breakdown and Data Triangulation
• 15.2 Data Source
  • 15.2.1 Secondary Sources
  • 15.2.2 Primary Sources
• 15.3 Author List